Motor symptoms in Parkinson's disease (PD) correlate with an excess in synchrony in the beta frequency band (13-30Hz) of local field potentials recorded from basal ganglia circuits. Recent results have suggested that this abnormal activity arises as a result of changes in specific dynamical features of the underlying neural signatures. In particular, patterns of activity in the beta band have been shown to be structured in bursts of longer durations and higher amplitudes in untreated patients with PD. Closed-loop deep brain stimulation (DBS) paradigms that specifically target these pathological bursts of activity hold promises to help trim, and thus normalize, their abnormal behavior in real-time. Here, we developed classification algorithm...
Background: Resting state beta band (13–30 Hz) oscillations represent pathological neural activity i...
Deep Brain Stimulation (DBS) is an established therapy for advanced Parkinson's disease (PD). Recent...
Objective Subthalamic nucleus (STN) beta activity (13–30 Hz) is the most accepted biomarker for a...
Motor symptoms in Parkinson's disease (PD) correlate with an excess in synchrony in the beta frequen...
Parkinson’s disease motor symptoms are associated with an increase in subthalamic nucleus beta band ...
Our understanding of the pathophysiology Parkinson’s disease has transformed over the last decade as...
Deep brain stimulation (DBS) electrodes provide an unparalleled window to record and investigate neu...
Parkinson's Disease (PD) affects 1% of the world population, with this number expected to increase w...
Our understanding of the pathophysiology Parkinson’s disease has transformed over the last decade as...
IntroductionParkinson's disease (PD) is a movement disorder characterized by the pathological beta b...
Exaggerated basal ganglia beta activity (13-35 Hz) is commonly found in patients with Parkinson's di...
Exaggerated basal ganglia beta activity (13-35 Hz) is commonly found in patients with Parkinson's di...
Essential tremor and Parkinson’s disease are the most common movement disorders affecting patients g...
This study presents a computational model of closed-loop control of deep brain stimulation (DBS) for...
BACKGROUND: Deep brain stimulation (DBS) holds great promise in treating various brain diseases but ...
Background: Resting state beta band (13–30 Hz) oscillations represent pathological neural activity i...
Deep Brain Stimulation (DBS) is an established therapy for advanced Parkinson's disease (PD). Recent...
Objective Subthalamic nucleus (STN) beta activity (13–30 Hz) is the most accepted biomarker for a...
Motor symptoms in Parkinson's disease (PD) correlate with an excess in synchrony in the beta frequen...
Parkinson’s disease motor symptoms are associated with an increase in subthalamic nucleus beta band ...
Our understanding of the pathophysiology Parkinson’s disease has transformed over the last decade as...
Deep brain stimulation (DBS) electrodes provide an unparalleled window to record and investigate neu...
Parkinson's Disease (PD) affects 1% of the world population, with this number expected to increase w...
Our understanding of the pathophysiology Parkinson’s disease has transformed over the last decade as...
IntroductionParkinson's disease (PD) is a movement disorder characterized by the pathological beta b...
Exaggerated basal ganglia beta activity (13-35 Hz) is commonly found in patients with Parkinson's di...
Exaggerated basal ganglia beta activity (13-35 Hz) is commonly found in patients with Parkinson's di...
Essential tremor and Parkinson’s disease are the most common movement disorders affecting patients g...
This study presents a computational model of closed-loop control of deep brain stimulation (DBS) for...
BACKGROUND: Deep brain stimulation (DBS) holds great promise in treating various brain diseases but ...
Background: Resting state beta band (13–30 Hz) oscillations represent pathological neural activity i...
Deep Brain Stimulation (DBS) is an established therapy for advanced Parkinson's disease (PD). Recent...
Objective Subthalamic nucleus (STN) beta activity (13–30 Hz) is the most accepted biomarker for a...